Eli Lilly's Retatrutide Shows Promise in Reducing Sleep Apnea Severity in Clinical Trials
Rapid Read

Eli Lilly's Retatrutide Shows Promise in Reducing Sleep Apnea Severity in Clinical Trials

What's Happening? Eli Lilly's experimental weekly injection, retatrutide, has demonstrated significant efficacy in reducing the severity of obstructive sleep apnea (OSA) in adults with obesity, according to peer-reviewed trials published in The New England Journal of Medicine. In non-diabetic partic
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.